Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept vs Placebo for Cancer-Associated Weight Loss and Anorexia
NCT00046904Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- May 2003
- Primary completion
- Sep 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cachexia and anorexia nervosa (AN) comparing Etanercept with Placebo (2 arms). Primary endpoint: Comparison of weight gain and rate of weight change up to 24 weeks. Started May 2003; status: completed.
02
Drugs
etanercept
03
Conditions
cachexiaanorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00046904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046904.